marketcaparena
Search

    LFVN

    Lifevantage Corp

    Company overview

    Market capitalization
    $77.54M
    Employees
    232
    Latest publication
    2026-09-29
    About Lifevantage Corp

    LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Total Revenue42,377,000USD43,716,000USD48,931,000USD47,561,000USD55,114,000USD58,440,000USD67,762,000USD47,214,000USD
    Cost Of Revenue9,334,000USD9,172,000USD12,722,000USD9,745,000USD11,065,000USD11,113,000USD13,195,000USD9,491,000USD
    Gross Profit33,043,000USD34,544,000USD36,209,000USD37,816,000USD44,049,000USD47,327,000USD54,567,000USD37,723,000USD
    Selling General Administrative13,874,000USD13,865,000USD15,827,000USD17,066,000USD18,679,000USD17,066,000USD18,614,000USD14,848,000USD
    Total Operating Expenses31,377,000USD32,866,000USD35,722,000USD35,548,000USD41,901,000USD43,274,000USD51,139,000USD35,153,000USD
    Operating Income1,666,000USD1,678,000USD487,000USD2,268,000USD2,148,000USD4,053,000USD3,428,000USD2,570,000USD
    Income Before Tax1,696,000USD1,656,000USD473,000USD2,241,000USD2,396,000USD4,180,000USD3,089,000USD2,578,000USD
    Income Tax Expense417,000USD294,000USD197,000USD86,000USD437,000USD710,000USD539,000USD752,000USD
    Net Income1,279,000USD1,362,000USD276,000USD2,155,000USD1,959,000USD3,470,000USD2,550,000USD1,826,000USD
    Unclassified Operating Expenses—19,001,000USD19,895,000USD18,482,000USD22,822,000USD25,808,000USD32,525,000USD—
    Interest Income—24,000USD20,000USD87,000USD111,000USD131,000USD130,000USD59,000USD
    Net Interest Income—24,000USD20,000USD87,000USD111,000USD131,000USD130,000USD59,000USD
    Tax Provision—294,000USD197,000USD86,000USD437,000USD710,000USD539,000USD752,000USD
    Net Income From Continuing Ops—1,362,000USD276,000USD2,155,000USD1,959,000USD3,470,000USD2,550,000USD1,826,000USD
    Ebit—1,678,000USD487,000USD2,268,000USD2,148,000USD4,053,000USD3,428,000USD2,570,000USD
    Ebitda—2,392,000USD1,239,000USD2,878,000USD2,898,000USD4,856,000USD4,234,000USD3,367,000USD
    Depreciation And Amortization—714,000USD752,000USD610,000USD750,000USD803,000USD806,000USD797,000USD
    Reconciled Depreciation—714,000USD752,000USD610,000USD750,000USD803,000USD806,000USD797,000USD
    Total Other Income Expense Net—-22,000USD-14,000USD-27,000USD248,000USD127,000USD-339,000USD8,000USD
    Research Development————400,000USD400,000USD—300,000USD
    Selling And Marketing Expenses———————20,305,000USD
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Revenue182,586,000USD228,530,000USD200,164,000USD213,398,000USD206,360,000USD220,181,000USD232,915,000USD225,958,000USD
    Cost Of Revenue40,973,000USD44,864,000USD41,440,000USD43,387,000USD38,097,000USD38,187,000USD37,964,000USD37,973,000USD
    Gross Profit141,613,000USD183,666,000USD158,724,000USD170,011,000USD168,263,000USD181,994,000USD194,951,000USD187,985,000USD
    Research Development1,000,000USD—700,000USD600,000USD700,000USD700,000USD900,000USD1,100,000USD
    Selling General Administrative58,419,000USD69,207,000USD68,472,000USD71,065,000USD63,425,000USD60,838,000USD67,914,000USD69,551,000USD
    Total Operating Expenses135,513,000USD171,467,000USD154,392,000USD165,752,000USD160,688,000USD164,379,000USD179,485,000USD178,171,000USD
    Operating Income6,100,000USD12,199,000USD4,332,000USD4,259,000USD7,575,000USD17,615,000USD15,466,000USD9,491,000USD
    Total Other Income Expense Net-34,000USD44,000USD18,000USD-458,000USD-2,884,000USD-383,000USD-805,000USD-584,000USD
    Income Before Tax6,066,000USD12,243,000USD4,350,000USD3,999,000USD4,691,000USD17,232,000USD14,661,000USD9,230,000USD
    Income Tax Expense994,000USD2,438,000USD1,413,000USD1,459,000USD1,571,000USD4,338,000USD3,112,000USD1,801,000USD
    Net Income5,072,000USD9,805,000USD2,937,000USD2,540,000USD3,120,000USD12,894,000USD11,549,000USD7,429,000USD
    Unclassified Operating Expenses—102,260,000USD——————
    Interest Income—431,000USD430,000USD198,000USD———731,000USD
    Net Interest Income—431,000USD430,000USD198,000USD-10,000USD-17,000USD-120,000USD-323,000USD
    Tax Provision—2,438,000USD1,413,000USD1,459,000USD1,571,000USD4,338,000USD3,112,000USD1,801,000USD
    Net Income From Continuing Ops—9,805,000USD2,937,000USD2,540,000USD3,120,000USD12,894,000USD11,549,000USD7,429,000USD
    Ebit—12,199,000USD4,332,000USD4,259,000USD4,701,000USD17,615,000USD14,781,000USD9,553,000USD
    Ebitda—15,355,000USD7,913,000USD7,838,000USD7,962,000USD21,075,000USD19,881,000USD11,448,000USD
    Depreciation And Amortization—3,156,000USD3,581,000USD3,579,000USD3,261,000USD3,460,000USD5,100,000USD1,895,000USD
    Reconciled Depreciation—3,156,000USD3,581,000USD3,579,000USD5,047,000USD5,825,000USD5,100,000USD1,895,000USD
    Selling And Marketing Expenses——85,920,000USD94,687,000USD97,263,000USD103,541,000USD111,571,000USD108,620,000USD
    Interest Expense———198,000USD10,000USD17,000USD120,000USD323,000USD
    Non Operating Income Net Other———-458,000USD—-366,000USD-685,000USD-261,000USD
    Net Income Applicable To Common Shares———2,540,000USD3,120,000USD12,894,000USD11,549,000USD7,429,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Total Assets62,111,000USD62,127,000USD61,169,000USD61,579,000USD68,527,000USD68,527,000USD61,460,000USD61,460,000USD
    Total Current Assets38,297,000USD39,314,000USD38,557,000USD45,048,000USD45,790,000USD45,790,000USD38,815,000USD38,815,000USD
    Other Current Assets2,834,000USD6,029,000USD4,416,000USD3,640,000USD4,641,000USD4,641,000USD3,451,000USD4,337,000USD
    Other Non Current Assets637,000USD———————
    Total Liabilities28,522,000USD———————
    Total Current Liabilities20,227,000USD20,101,000USD19,013,000USD18,829,000USD27,549,000USD27,549,000USD22,072,000USD22,072,000USD
    Other Current Liabilities7,412,000USD———————
    Other Non Current Liabilities362,000USD———————
    Total Stockholder Equity33,589,000USD33,339,000USD32,987,000USD33,156,999USD29,889,000USD29,889,000USD27,697,000USD27,697,000USD
    Total Equity Including Noncontrolling Interest33,589,000USD———————
    Deferred Revenue1,148,000USD———————
    Net Receivables2,990,000USD2,420,000USD4,982,000USD7,723,000USD2,087,000USD2,087,000USD3,854,000USD2,968,000USD
    Inventory16,167,000USD18,382,000USD18,978,000USD20,594,000USD17,467,000USD17,467,000USD16,914,000USD16,914,000USD
    Property Plant Equipment Net14,025,000USD13,758,000USD13,700,000USD13,661,000USD16,051,000USD16,051,000USD16,886,000USD16,886,000USD
    Goodwill465,000USD———————
    Intangible Assets3,058,000USD3,187,000USD3,316,000USD245,000USD257,000USD257,000USD290,000USD290,000USD
    Accounts Payable5,156,000USD5,147,000USD4,891,000USD4,356,000USD5,757,000USD5,757,000USD5,270,000USD5,270,000USD
    Short Term Debt1,935,000USD1,885,000USD1,891,000USD1,881,000USD1,886,000USD1,886,000USD1,897,000USD1,897,000USD
    Common Stock1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
    Retained Earnings-103,462,000USD-103,656,000USD-103,441,000USD-103,141,000USD-106,478,000USD-106,478,000USD-108,526,000USD-108,526,000USD
    Accumulated Other Comprehensive Income-1,874,000USD-1,732,000USD-1,614,000USD-1,354,999USD-1,805,000USD-1,805,000USD-1,125,000USD-1,125,000USD
    Total Liab—28,788,000USD28,182,000USD28,422,000USD38,638,000USD38,638,000USD33,763,000USD33,763,000USD
    Other Current Liab—13,069,000USD12,231,000USD12,592,000USD19,246,000USD19,246,000USD14,858,000USD14,858,000USD
    Capital Stock—1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
    Good Will—472,000USD472,000USD—————
    Cash—12,483,000USD10,181,000USD13,091,000USD21,595,000USD21,595,000USD14,596,000USD14,596,000USD
    Cash And Short Term Investments—12,483,000USD10,181,000USD13,091,000USD21,595,000USD21,595,000USD14,596,000USD14,596,000USD
    Net Debt—-2,277,000USD510,000USD-1,900,000USD-8,826,000USD-8,826,000USD-1,233,000USD-1,233,000USD
    Short Long Term Debt Total—10,206,000USD10,691,000USD11,191,000USD12,769,000USD12,769,000USD13,363,000USD13,363,000USD
    Property Plant Equipment Gross—13,758,000USD13,700,000USD13,661,000USD31,660,000USD15,337,000USD16,051,000USD16,886,000USD
    Common Stock Shares Outstanding—12,660,000shares12,745,000shares12,946,000shares13,128,000shares13,300,000shares13,177,000shares12,824,000shares
    Non Current Assets Total—22,813,000USD22,612,000USD16,531,000USD22,737,000USD22,737,000USD22,645,000USD22,645,000USD
    Non Current Liabilities Total—8,687,000USD9,169,000USD9,593,000USD11,089,000USD11,089,000USD11,691,000USD11,691,000USD
    Non Current Liabilities Other—366,000USD369,000USD283,000USD289,000USD218,000USD206,000USD225,000USD
    Non Currrent Assets Other—591,000USD610,000USD636,000USD645,000USD645,000USD685,000USD685,000USD
    Net Working Capital—19,213,000USD19,544,000USD26,219,000USD23,677,000USD21,531,000USD18,241,000USD16,743,000USD
    Unclassified Non Current Assets—4,805,000USD4,514,000USD1,989,000USD5,784,000USD5,784,000USD4,784,000USD4,784,000USD
    Unclassified Non Current Liabilities—8,321,000USD8,800,000USD9,310,000USD10,800,000USD10,871,000USD11,485,000USD11,466,000USD
    Unclassified Equity—138,725,000USD138,040,000USD137,650,998USD138,170,000USD138,170,000USD137,346,000USD137,346,000USD
    Current Deferred Revenue——700,000USD—711,000USD——1,100,000USD
    Unclassified Current Liabilities———————-1,053,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Assets62,111,000USD71,958,000USD60,299,000USD66,123,000USD70,706,000USD78,732,000USD58,877,000USD55,273,000USD
    Total Current Assets38,297,000USD50,894,000USD37,646,000USD44,284,000USD46,957,000USD48,054,000USD43,868,000USD43,188,000USD
    Other Current Assets2,834,000USD6,095,000USD2,443,000USD4,753,000USD5,205,000USD4,772,000USD5,232,000USD7,309,000USD
    Other Non Current Assets637,000USD———————
    Total Liabilities28,522,000USD———————
    Total Current Liabilities20,227,000USD27,217,000USD22,309,000USD19,609,000USD25,728,000USD25,199,000USD25,019,000USD26,195,000USD
    Other Current Liabilities7,412,000USD———————
    Other Non Current Liabilities362,000USD———————
    Total Stockholder Equity33,589,000USD34,641,000USD25,991,000USD34,649,000USD31,516,000USD36,807,000USD33,254,000USD27,199,000USD
    Total Equity Including Noncontrolling Interest33,589,000USD———————
    Deferred Revenue1,148,000USD———————
    Net Receivables2,990,000USD3,929,000USD3,262,000USD1,853,000USD5,090,000USD3,963,000USD2,610,000USD3,302,000USD
    Inventory16,167,000USD20,669,000USD15,055,000USD16,073,000USD16,472,000USD16,145,000USD13,888,000USD13,753,000USD
    Property Plant Equipment Net14,025,000USD14,248,000USD17,382,000USD17,824,000USD20,540,000USD24,823,000USD8,126,000USD7,131,000USD
    Goodwill465,000USD———————
    Intangible Assets3,058,000USD245,000USD323,000USD455,000USD587,000USD719,000USD851,000USD983,000USD
    Accounts Payable5,156,000USD5,059,000USD6,287,000USD4,225,000USD7,923,000USD7,591,000USD4,611,000USD5,180,000USD
    Short Term Debt1,935,000USD1,867,000USD1,811,000USD1,521,000USD2,601,000USD2,151,000USD1,184,000USD1,454,000USD
    Common Stock1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
    Retained Earnings-103,462,000USD-104,147,000USD-108,738,000USD-98,305,000USD-98,437,000USD-92,346,000USD-93,307,000USD-99,960,000USD
    Accumulated Other Comprehensive Income-1,874,000USD-1,175,000USD-1,916,000USD-1,361,000USD-1,123,000USD104,000USD144,000USD62,000USD
    Total Liab—37,317,000USD34,308,000USD31,474,000USD39,190,000USD41,925,000USD25,623,000USD28,074,000USD
    Other Current Liab—17,391,000USD10,891,000USD11,299,000USD12,920,000USD12,349,000USD15,607,000USD17,971,000USD
    Capital Stock—1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
    Cash—20,201,000USD16,886,000USD21,605,000USD20,190,000USD23,174,000USD22,138,000USD18,824,000USD
    Cash And Short Term Investments—20,201,000USD16,886,000USD21,605,000USD20,190,000USD23,174,000USD22,138,000USD18,824,000USD
    Current Deferred Revenue—711,000USD860,000USD834,000USD78,000USD319,000USD792,000USD998,000USD
    Net Debt—-8,523,000USD-3,274,000USD-8,518,000USD-4,435,000USD-4,991,000USD-20,954,000USD-17,370,000USD
    Short Long Term Debt Total—11,678,000USD13,612,000USD13,087,000USD15,755,000USD18,183,000USD1,184,000USD1,454,000USD
    Property Plant Equipment Gross—31,660,000USD31,892,000USD17,824,000USD20,540,000USD24,823,000USD8,126,000USD7,131,000USD
    Common Stock Shares Outstanding—12,987,000shares12,986,000shares12,567,000shares13,069,000shares14,268,000shares14,599,000shares14,980,000shares
    Non Current Assets Total—21,064,000USD22,653,000USD21,839,000USD23,749,000USD30,678,000USD15,009,000USD12,085,000USD
    Non Current Liabilities Total—10,100,000USD11,999,000USD11,865,000USD13,462,000USD16,726,000USD604,000USD1,879,000USD
    Non Current Liabilities Other—289,000USD198,000USD11,865,000USD308,000USD694,000USD604,000USD1,879,000USD
    Non Currrent Assets Other—601,000USD680,000USD569,000USD1,333,000USD1,723,000USD1,663,000USD1,278,000USD
    Net Working Capital—23,677,000USD15,337,000USD24,675,000USD21,229,000USD22,855,000USD18,849,000USD16,993,000USD
    Unclassified Non Current Assets—5,970,000USD4,268,000USD—-1,333,000USD-1,723,000USD-1,663,000USD-1,278,000USD
    Unclassified Current Liabilities—2,189,000USD2,460,000USD1,730,000USD2,206,000USD2,789,000USD2,825,000USD—
    Unclassified Non Current Liabilities—9,811,000USD11,801,000USD—12,846,000USD15,338,000USD—-1,879,000USD
    Unclassified Equity—139,961,000USD136,643,000USD134,313,000USD131,074,000USD129,047,000USD126,415,000USD127,095,000USD
    Other Liab———299,000USD308,000USD694,000USD604,000USD1,879,000USD
    Other Assets———3,560,000USD2,622,000USD2,931,000USD3,827,000USD3,971,000USD
    Net Tangible Assets———34,194,000USD30,929,000USD36,088,000USD32,403,000USD26,216,000USD
    Long Term Investments————0USD2,205,000USD2,205,000USD0USD
    Short Long Term Debt———————1,454,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Depreciation2,773,000USD3,156,000USD3,581,000USD3,579,000USD5,047,000USD3,261,000USD5,100,000USD1,895,000USD
    Stock Based Compensation2,346,000USD5,702,000USD3,280,000USD3,188,000USD1,768,000USD1,768,000USD4,919,000USD5,525,000USD
    Deferred Income Tax377,000USD———————
    Change To Account Receivables200,000USD-564,000USD-1,495,000USD1,558,000USD-614,000USD-1,327,000USD-539,000USD-771,000USD
    Change To Inventory2,019,000USD-5,216,000USD662,000USD61,000USD-1,186,000USD-1,186,000USD-152,000USD-64,000USD
    Change To Liabilities-6,992,000USD——-4,948,000USD824,000USD3,214,000USD-988,000USD2,134,000USD
    Change In Working Capital2,868,000USD-6,550,000USD2,380,000USD-2,558,000USD-4,100,000USD-4,100,000USD-3,652,000USD2,335,000USD
    Operating Cash Flow10,241,000USD———————
    Capital Expenditures-3,571,000USD-1,371,000USD-2,245,000USD-3,067,000USD-1,530,000USD-1,530,000USD-2,681,000USD-2,506,000USD
    Unclassified Investing Cash Flow-3,743,000USD1,367,000USD2,241,000USD3,059,000USD3,060,000USD3,727,000USD5,362,000USD4,506,000USD
    Investing Cash Flow-7,314,000USD———————
    Net Common Stock Issuance-5,659,000USD———————
    Common Dividends Paid-2,344,000USD———————
    Unclassified Financing Cash Flow220,000USD2,944,000USD——————
    Financing Cash Flow-7,783,000USD———————
    Effect Of Forex Changes On Cash-425,000USD———————
    Change In Cash-5,281,000USD3,315,000USD-4,719,000USD1,415,000USD-2,984,000USD-2,984,000USD3,314,000USD2,172,000USD
    End Cash Flow14,920,000USD———————
    Net Income—9,805,000USD2,937,000USD2,540,000USD3,120,000USD3,120,000USD11,549,000USD7,429,000USD
    Other Non Cash Items—1,468,000USD1,296,000USD1,781,000USD2,205,000USD3,991,000USD46,000USD42,000USD
    Total Cash From Operating Activities—11,878,000USD12,197,000USD6,828,000USD7,959,000USD7,959,000USD18,326,000USD17,789,000USD
    Free Cash Flow—10,507,000USD9,952,000USD3,761,000USD6,429,000USD6,429,000USD15,645,000USD15,283,000USD
    Investments—-1,367,000USD-2,245,000USD-3,059,000USD-1,530,000USD-3,734,000USD-2,681,000USD-4,506,000USD
    Total Cashflows From Investing Activities—-1,367,000USD-2,245,000USD-3,059,000USD-1,530,000USD-1,530,000USD-2,681,000USD-4,506,000USD
    Total Cash From Financing Activities—-7,598,000USD-14,417,000USD-2,357,000USD-8,952,000USD-8,952,000USD-12,422,000USD-11,121,000USD
    Dividends Paid—-2,067,000USD-6,940,000USD-1,586,000USD-378,000USD-378,000USD-653,000USD-701,000USD
    Sale Purchase Of Stock—-5,811,000USD-7,651,000USD-1,023,000USD-9,079,000USD-9,079,000USD-11,651,000USD-7,822,000USD
    Begin Period Cash Flow—16,886,000USD21,605,000USD20,190,000USD23,174,000USD23,174,000USD18,824,000USD16,652,000USD
    End Period Cash Flow—20,201,000USD16,886,000USD21,605,000USD20,190,000USD20,190,000USD22,138,000USD18,824,000USD
    Other Cashflows From Investing Activities—4,000USD4,000USD8,000USD-1,530,000USD7,000USD-2,681,000USD-2,000,000USD
    Other Cashflows From Financing Activities—-2,664,000USD-97,000USD201,000USD133,000USD505,000USD729,000USD701,000USD
    Unclassified Operating Cash Flow—-1,703,000USD-1,277,000USD-1,702,000USD————
    Cash And Cash Equivalents Changes———1,412,000USD—1,086,000USD3,223,000USD2,162,000USD
    Net Borrowings————0USD—-1,500,000USD-4,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USDQ4 20242024-06-30 · USD
    Net Income1,362,000USD276,000USD2,155,000USD1,959,000USD3,470,000USD2,550,000USD1,826,000USD1,305,000USD
    Depreciation714,000USD752,000USD610,000USD750,000USD803,000USD806,000USD797,000USD806,000USD
    Stock Based Compensation704,000USD553,000USD826,000USD1,542,000USD1,521,000USD1,722,000USD917,000USD756,000USD
    Other Non Cash Items1,232,000USD2,427,000USD357,000USD380,000USD367,000USD364,000USD357,000USD376,000USD
    Change To Account Receivables346,000USD2,699,000USD-3,819,000USD-640,000USD-1,109,000USD1,677,000USD-492,000USD-825,000USD
    Change To Inventory263,000USD-350,000USD-29,000USD1,860,000USD-4,603,000USD-970,000USD-1,503,000USD-63,000USD
    Change In Working Capital1,971,000USD1,258,000USD-10,235,000USD-4,514,000USD-2,829,000USD4,758,000USD-3,965,000USD-1,320,000USD
    Total Cash From Operating Activities4,988,000USD2,791,000USD-2,305,000USD1,034,000USD2,228,000USD9,199,000USD-583,000USD2,582,000USD
    Capital Expenditures-1,011,000USD-1,084,000USD-439,000USD-199,000USD-331,000USD-492,000USD-349,000USD-278,000USD
    Free Cash Flow3,977,000USD1,707,000USD-2,744,000USD835,000USD1,897,000USD8,707,000USD-932,000USD2,304,000USD
    Total Cashflows From Investing Activities-1,010,999USD-4,827,000USD-439,000USD-199,000USD-331,000USD-492,000USD-345,000USD-278,000USD
    Net Borrowings0USD———0USD———
    Total Cash From Financing Activities-1,598,000USD-738,000USD-4,297,000USD-3,243,000USD-1,127,000USD-1,400,000USD-1,828,000USD-2,741,000USD
    Dividends Paid-573,000USD-575,000USD-571,000USD-562,000USD-503,000USD-502,000USD-500,000USD-503,000USD
    Sale Purchase Of Stock-1,006,000USD-163,000USD-3,862,000USD-4,697,000USD1,245,000USD-898,000USD-1,461,000USD-3,052,000USD
    Change In Cash2,302,000USD-2,910,000USD-7,110,000USD-2,268,000USD874,000USD6,999,000USD-2,290,000USD-491,000USD
    Begin Period Cash Flow10,181,000USD13,091,000USD20,201,000USD22,469,000USD21,595,000USD14,596,000USD16,886,000USD17,377,000USD
    End Period Cash Flow12,483,000USD10,181,000USD13,091,000USD20,201,000USD22,469,000USD21,595,000USD14,596,000USD16,886,000USD
    Other Cashflows From Financing Activities-103,000USD-164,000USD-12,000USD2,016,000USD-2,016,000USD-898,000USD133,000USD814,000USD
    Other Cashflows From Investing Activities—-3,743,000USD————4,000USD-2,245,000USD
    Unclassified Operating Cash Flow—-2,475,000USD3,982,000USD—-1,104,000USD-1,001,000USD——
    Investments——-439,000USD-199,000USD-331,000USD-492,000USD-345,000USD-278,000USD
    Unclassified Investing Cash Flow———————2,523,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q3 2026Quarterly · 2026-03-31ProductAXIOProduct Line3,432,000USD0001193125-26-208922
    Q3 2026Quarterly · 2026-03-31ProductLife Vantage Product Line6,318,000USD0001193125-26-208922
    Q3 2026Quarterly · 2026-03-31ProductLove Biome Product Line3,177,000USD0001193125-26-208922
    Q3 2026Quarterly · 2026-03-31ProductPetandim Product Line466,000USD0001193125-26-208922
    Q3 2026Quarterly · 2026-03-31ProductPhys IQProduct Line847,000USD0001193125-26-208922
    Q3 2026Quarterly · 2026-03-31ProductProduct And Service Other632,000USD0001193125-26-208922
    Q3 2026Quarterly · 2026-03-31ProductProtandim19,951,000USD0001193125-26-208922
    Q3 2026Quarterly · 2026-03-31ProductTrue Science Product Line8,893,000USD0001193125-26-208922
    Q2 2026Quarterly · 2025-12-31ProductAXIOProduct Line3,918,000USD0001628280-26-005428
    Q2 2026Quarterly · 2025-12-31ProductLife Vantage Product Line7,221,000USD0001628280-26-005428
    Q2 2026Quarterly · 2025-12-31ProductLove Biome Product Line4,065,000USD0001628280-26-005428
    Q2 2026Quarterly · 2025-12-31ProductPetandim Product Line501,000USD0001628280-26-005428
    Q2 2026Quarterly · 2025-12-31ProductPhys IQProduct Line1,050,000USD0001628280-26-005428
    Q2 2026Quarterly · 2025-12-31ProductProduct And Service Other1,164,000USD0001628280-26-005428
    Q2 2026Quarterly · 2025-12-31ProductProtandim20,928,000USD0001628280-26-005428
    Q2 2026Quarterly · 2025-12-31ProductTrue Science Product Line10,084,000USD0001628280-26-005428
    Q1 2026Quarterly · 2025-09-30ProductAXIOProduct Line3,458,000USD0001628280-25-048792
    Q1 2026Quarterly · 2025-09-30ProductLife Vantage True Science Skin Care Regimen9,867,000USD0001628280-25-048792
    Q1 2026Quarterly · 2025-09-30ProductPetandim Product Line477,000USD0001628280-25-048792
    Q1 2026Quarterly · 2025-09-30ProductPhys IQProduct Line1,236,000USD0001628280-25-048792
    Q1 2026Quarterly · 2025-09-30ProductProduct And Service Other1,361,000USD0001628280-25-048792
    Q1 2026Quarterly · 2025-09-30ProductProtandim22,057,000USD0001628280-25-048792
    Q1 2026Quarterly · 2025-09-30ProductTrue Science Product Line9,105,000USD0001628280-25-048792
    FY 2025Yearly · 2025-06-30ProductAXIOProduct Line15,312,000USD0000849146-25-000068
    FY 2025Yearly · 2025-06-30ProductLife Vantage True Science Skin Care Regimen56,225,000USD0000849146-25-000068
    FY 2025Yearly · 2025-06-30ProductPetandim Product Line2,117,000USD0000849146-25-000068
    FY 2025Yearly · 2025-06-30ProductPhys IQProduct Line5,102,000USD0000849146-25-000068
    FY 2025Yearly · 2025-06-30ProductProduct And Service Other5,734,000USD0000849146-25-000068
    FY 2025Yearly · 2025-06-30ProductProtandim95,328,000USD0000849146-25-000068
    FY 2025Yearly · 2025-06-30ProductTrue Science Product Line48,712,000USD0000849146-25-000068
    Q3 2025Quarterly · 2025-03-31ProductAXIOProduct Line3,894,000USD0001193125-26-208922
    Q3 2025Quarterly · 2025-03-31ProductLife Vantage Product Line16,270,000USD0001193125-26-208922
    Q3 2025Quarterly · 2025-03-31ProductLove Biome Product Line0USD0001193125-26-208922
    Q3 2025Quarterly · 2025-03-31ProductPetandim Product Line553,000USD0001193125-26-208922
    Q3 2025Quarterly · 2025-03-31ProductPhys IQProduct Line1,365,000USD0001193125-26-208922
    Q3 2025Quarterly · 2025-03-31ProductProduct And Service Other1,166,000USD0001193125-26-208922
    Q3 2025Quarterly · 2025-03-31ProductProtandim23,497,000USD0001193125-26-208922
    Q3 2025Quarterly · 2025-03-31ProductTrue Science Product Line11,695,000USD0001193125-26-208922
    Q2 2025Quarterly · 2024-12-31ProductAXIOProduct Line3,537,000USD0001628280-26-005428
    Q2 2025Quarterly · 2024-12-31ProductLife Vantage Product Line23,736,000USD0001628280-26-005428
    Q2 2025Quarterly · 2024-12-31ProductLove Biome Product Line0USD0001628280-26-005428
    Q2 2025Quarterly · 2024-12-31ProductPetandim Product Line508,000USD0001628280-26-005428
    Q2 2025Quarterly · 2024-12-31ProductPhys IQProduct Line1,273,000USD0001628280-26-005428
    Q2 2025Quarterly · 2024-12-31ProductProduct And Service Other1,201,000USD0001628280-26-005428
    Q2 2025Quarterly · 2024-12-31ProductProtandim24,540,000USD0001628280-26-005428
    Q2 2025Quarterly · 2024-12-31ProductTrue Science Product Line12,967,000USD0001628280-26-005428
    Q1 2025Quarterly · 2024-09-30ProductAXIOProduct Line3,532,000USD0001628280-25-048792
    Q1 2025Quarterly · 2024-09-30ProductLife Vantage True Science Skin Care Regimen12,792,000USD0001628280-25-048792
    Q1 2025Quarterly · 2024-09-30ProductPetandim Product Line534,000USD0001628280-25-048792
    Q1 2025Quarterly · 2024-09-30ProductPhys IQProduct Line1,144,000USD0001628280-25-048792
    Q1 2025Quarterly · 2024-09-30ProductProduct And Service Other1,112,000USD0001628280-25-048792
    Q1 2025Quarterly · 2024-09-30ProductProtandim24,198,000USD0001628280-25-048792
    Q1 2025Quarterly · 2024-09-30ProductTrue Science Product Line3,902,000USD0001628280-25-048792
    FY 2024Yearly · 2024-06-30ProductAXIOProduct Line13,375,000USD0000849146-25-000068
    FY 2024Yearly · 2024-06-30ProductLife Vantage True Science Skin Care Regimen15,675,000USD0000849146-25-000068
    FY 2024Yearly · 2024-06-30ProductPetandim Product Line2,398,000USD0000849146-25-000068
    FY 2024Yearly · 2024-06-30ProductPhys IQProduct Line3,827,000USD0000849146-25-000068
    FY 2024Yearly · 2024-06-30ProductProduct And Service Other4,502,000USD0000849146-25-000068
    FY 2024Yearly · 2024-06-30ProductProtandim104,135,000USD0000849146-25-000068
    FY 2024Yearly · 2024-06-30ProductTrue Science Product Line56,252,000USD0000849146-25-000068
    FY 2023Yearly · 2023-06-30ProductLife Vantage True Science Skin Care Regimen49,494,000USD0000849146-24-000073
    FY 2023Yearly · 2023-06-30ProductProduct And Service Other44,184,000USD0000849146-24-000073
    FY 2023Yearly · 2023-06-30ProductProtandim119,720,000USD0000849146-24-000073
    FY 2022Yearly · 2022-06-30ProductLife Vantage True Science Skin Care Regimen22,877,000USD0000849146-23-000102
    FY 2022Yearly · 2022-06-30ProductProduct And Service Other47,867,000USD0000849146-23-000102
    FY 2022Yearly · 2022-06-30ProductProtandim135,616,000USD0000849146-23-000102
    FY 2021Yearly · 2021-06-30ProductLife Vantage True Science Skin Care Regimen22,617,000USD0000849146-22-000058
    FY 2021Yearly · 2021-06-30ProductProduct And Service Other47,292,000USD0000849146-22-000058
    FY 2021Yearly · 2021-06-30ProductProtandim150,272,000USD0000849146-22-000058
    FY 2020Yearly · 2020-06-30ProductLife Vantage True Science Skin Care Regimen23,739,000USD0000849146-22-000058
    FY 2020Yearly · 2020-06-30ProductProduct And Service Other52,841,000USD0000849146-22-000058
    FY 2020Yearly · 2020-06-30ProductProtandim156,335,000USD0000849146-22-000058
    FY 2019Yearly · 2019-06-30ProductLife Vantage True Science Skin Care Regimen24,853,000USD0000849146-21-000078
    FY 2019Yearly · 2019-06-30ProductProduct And Service Other57,005,000USD0000849146-21-000078
    FY 2019Yearly · 2019-06-30ProductProtandim144,100,000USD0000849146-21-000078
    FY 2018Yearly · 2018-06-30ProductLife Vantage True Science Skin Care Regimen20,881,000USD0000849146-20-000115
    FY 2018Yearly · 2018-06-30ProductProduct And Service Other52,229,000USD0000849146-20-000115
    FY 2018Yearly · 2018-06-30ProductProtandim130,094,000USD0000849146-20-000115
    Q3 2018Quarterly · 2018-03-31GeographyAmericas38,026,000USD0000849146-18-000057
    Q3 2018Quarterly · 2018-03-31GeographyAsia Pacific12,536,000USD0000849146-18-000057
    Q2 2018Quarterly · 2017-12-31GeographyAmericas36,903,000USD0000849146-18-000041
    Q2 2018Quarterly · 2017-12-31GeographyAsia Pacific12,579,000USD0000849146-18-000041
    Q1 2018Quarterly · 2017-09-30GeographyAmericas36,163,000USD0000849146-17-000117
    Q1 2018Quarterly · 2017-09-30GeographyAsia Pacific12,964,000USD0000849146-17-000117
    Q3 2017Quarterly · 2017-03-31GeographyAmericas34,379,000USD0000849146-18-000057
    Q3 2017Quarterly · 2017-03-31GeographyAsia Pacific10,628,000USD0000849146-18-000057
    Q2 2017Quarterly · 2016-12-31GeographyAmericas37,613,000USD0000849146-18-000041
    Q2 2017Quarterly · 2016-12-31GeographyAsia Pacific11,334,000USD0000849146-18-000041
    Q1 2017Quarterly · 2016-09-30GeographyAmericas40,135,000USD0000849146-17-000117
    Q1 2017Quarterly · 2016-09-30GeographyAsia Pacific14,759,000USD0000849146-17-000117
    Q3 2016Quarterly · 2016-03-31GeographyAmericas44,012,000USD0000849146-17-000081
    Q3 2016Quarterly · 2016-03-31GeographyAsia Pacific12,148,000USD0000849146-17-000081
    Q2 2016Quarterly · 2015-12-31GeographyAmericas40,055,000USD0000849146-17-000014
    Q2 2016Quarterly · 2015-12-31GeographyAsia Pacific11,940,000USD0000849146-17-000014

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.